Search - tctmd.com

Displaying 41 - 60 of 150

Sort: Relevancy | Date

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

Presentation TVT 2019

Use of a New-Generation Transcatheter Heart Valve Facilitating Valve-in-Valve TAVR and Bioprosthetic Valve Fracture in a Patient at High Risk of Coronary Obstruction

Presenter: Mark Hensey

June 14, 2019

Presentation TVT 2019

Left Main Coronary Artery Balloon Occlusion — A Simple Maneuver to Assess the Need of BASILICA

Presenter: Albert Chan

June 14, 2019

Presentation TVT 2019

Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

Presenter: Gilbert Tang

June 14, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Stanley Chetcuti

June 13, 2019

Presentation TVT 2019

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Coronary Access and Coronary Obstruction: The Achilles' Heel of Redo TAVR?

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Presenter: Luis Dallan

June 13, 2019

Presentation TVT 2019

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Presenter: Gilbert Tang

June 13, 2019

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Advertisement

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Newer TAVR Devices Reassure in Failed Surgical Valves

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Use of a New-Generation Transcatheter Heart Valve Facilitating Valve-in-Valve TAVR and Bioprosthetic Valve Fracture in a Patient at High Risk of Coronary Obstruction

Left Main Coronary Artery Balloon Occlusion — A Simple Maneuver to Assess the Need of BASILICA

Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Coronary Access and Coronary Obstruction: The Achilles' Heel of Redo TAVR?

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Life-Saving Procedure Planning: Predicted Coronary Occlusion and Impella Bailout in Valve-in-Valve Transcatheter Aortic Valve Replacement

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content